Clinical experience with ferric carboxymaltose in the treatment of cancer- and chemotherapy-associated anaemia
about
Iron deficiency in gastrointestinal oncologySafety and Efficacy of Ferric Carboxymaltose in Anemic Pregnant Women: A Retrospective Case Control StudyA European patient record study on diagnosis and treatment of chemotherapy-induced anaemia.Intravenous iron alone resolves anemia in patients with functional iron deficiency and lymphoid malignancies undergoing chemotherapy.Optimizing iron delivery in the management of anemia: patient considerations and the role of ferric carboxymaltose.Is there any role of intravenous iron for the treatment of anemia in cancer?Iron metabolism and iron supplementation in cancer patientsIron deficient erythropoiesis might play key role in development of anemia in cancer patients.Impact of a Patient Blood Management Program and an Outpatient Anemia Management Protocol on Red Cell Transfusions in Oncology Inpatients and OutpatientsIntravenous iron monotherapy for the treatment of non-iron-deficiency anemia in cancer patients undergoing chemotherapy: a pilot study.A Randomized Noninferiority Trial of Intravenous Iron Isomaltoside versus Oral Iron Sulfate in Patients with Nonmyeloid Malignancies and Anemia Receiving Chemotherapy: The PROFOUND Trial.Iron deficiency in cancer patients.Perioperative anemia management in colorectal cancer patients: a pragmatic approach.Diagnosis and treatment of cancer-related anemia.Iron sucrose - characteristics, efficacy and regulatory aspects of an established treatment of iron deficiency and iron-deficiency anemia in a broad range of therapeutic areas.Ferric carboxymaltose: a review of its use in iron deficiency.Intravenous iron therapy for anemic cancer patients: a review of recently published clinical studies.Single-dose intravenous iron for iron deficiency: a new paradigm.Use of iron sucrose and red blood cell transfusions in anaemic cancer patients in France (OncoFer study).The available intravenous iron formulations: History, efficacy, and toxicology.Clinical use of ferric carboxymaltose in patients with solid tumours or haematological malignancies in France.Current misconceptions in diagnosis and management of iron deficiencyIntravenous iron and safety: is the end of the debate on the horizon?The effectiveness of intravenous iron for iron deficiency anemia in gastrointestinal cancer patients: a retrospective study.Iron deficiency in patients with solid tumours: prevalence and management in clinical practice.Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial.Position paper on management of iron deficiency in adult cancer patients.Treatment of anemia in patients with solid tumors receiving chemotherapy in palliative setting: usual practice versus guidelines.Chemotherapy-related anemia.Hypophosphatemia, Severe Bone Pain, Gait Disturbance, and Fatigue Fractures After Iron Substitution in Inflammatory Bowel Disease: A Case Report.Induction of iron excess restricts malignant plasma cells expansion and potentiates bortezomib effect in models of multiple myeloma.Role of intravenous iron in the treatment of anemia in patients with gastrointestinal tract tumors undergoing chemotherapy: a single-center, observational study
P2860
Q27023196-F4DBE56E-898F-4B0E-8387-38DC0BD055E3Q28606630-633BDF92-41AB-4A2D-AE88-04A52E6D07C4Q33848929-AC236C68-330D-4431-BC88-8B2A6424BD8EQ34459582-31B8BE5F-68EE-4CD5-B332-47205BDAE792Q34700903-48E41BCE-93D2-46C8-9D9A-6061B860121FQ36108113-E62C7B49-38EC-4CA6-974F-FB3E1D68A344Q36371665-44D4147A-176E-4B54-AC71-31CBF5592B03Q36619022-2A1F5CAD-8412-4052-8DDF-D276ADB9A745Q36673495-5DB89D82-7654-43CB-9BD7-E90549C994BCQ37164472-F9C61FCC-89CE-4344-B553-4E9F6831334FQ37352255-0F4CB194-E1AE-463B-A05F-67DA493DD9E8Q37429231-21EFF418-F02F-4D48-91AD-EB0D65A291EDQ37602724-D4E87A24-E434-4A7A-AE6C-0311AA30CCBFQ38188501-2F014535-5485-4EB4-ACBC-B58120D14F0CQ38245887-B41CB7DA-07A3-4A63-A7E6-87887D90AF05Q38271890-79B7A0E1-C6A1-48EC-A410-C8D104DA8C42Q38733772-7C182390-2E58-4078-B1CF-9AF8042B3E5DQ39027699-E8C4506F-E995-4591-87B9-F811E4C70A47Q39132837-AD111701-4F26-4AD4-8B40-85FB7529AEEBQ39216462-BD3747DC-78C0-44FD-9426-20F7E3A2C123Q41002692-2CC1674A-C391-4886-B10C-75EEA30788AFQ41547046-277E5D38-53EB-42F0-8BF9-67B3E113F57AQ42750147-EC730071-E0C7-4387-BFF8-FA07591C1731Q43729473-EF1CC409-E26C-4A7D-AEB3-656D7283AD75Q45807225-0F3EA84D-0A47-44D9-881B-7C9CD142CA91Q47734653-33D93C9B-3573-45A9-A166-052C409D9E52Q48212676-92950FE4-AC38-453C-A1D3-9315A6E02477Q48237731-895A007D-9EB2-4063-937D-9F9CE2B04639Q48365358-A39F92F4-868B-4570-8FFC-193A461D0716Q50080883-06E9C937-358F-4791-AAF7-5767B1BDEB1DQ52821501-855DDF1F-D0DA-4A67-A9D9-19D1898B4D6EQ58719897-49EE3596-7724-42DD-99D5-E4EC4AAA29B7
P2860
Clinical experience with ferric carboxymaltose in the treatment of cancer- and chemotherapy-associated anaemia
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Clinical experience with ferri ...... hemotherapy-associated anaemia
@ast
Clinical experience with ferri ...... hemotherapy-associated anaemia
@en
type
label
Clinical experience with ferri ...... hemotherapy-associated anaemia
@ast
Clinical experience with ferri ...... hemotherapy-associated anaemia
@en
prefLabel
Clinical experience with ferri ...... hemotherapy-associated anaemia
@ast
Clinical experience with ferri ...... hemotherapy-associated anaemia
@en
P2093
P2860
P356
P1433
P1476
Clinical experience with ferri ...... hemotherapy-associated anaemia
@en
P2093
B Tschechne
N Marschner
R Rohrberg
T Steinmetz
P2860
P304
P356
10.1093/ANNONC/MDS338
P577
2012-10-15T00:00:00Z